LANDOS BIOPHARMA INC

LANDOS BIOPHARMA INC (LABP)

$2.99

+0.1

(+3.46%)

Live

Performance

  • $2.81
    $3.44
    $2.99
    downward going graph

    6.02%

    Downside

    Day's Volatility :18.31%

    Upside

    13.08%

    downward going graph
  • $0.21
    $2.99
    $2.99
    downward going graph

    92.94%

    Downside

    52 Weeks Volatility :92.94%

    Upside

    0.0%

    downward going graph

Returns

PeriodLANDOS BIOPHARMA INCSector (Health Care)Index (Russel 2000)
3 Months
680.87%
0.3%
-6.7%
6 Months
1244.19%
-8.3%
-6.2%
1 Year
297.96%
-4.8%
-6.3%
3 Years
-75.92%
23.8%
26.9%

Highlights

Market Capitalization
90.1M
Book Value
$1.51
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-6.13
Wall Street Target Price
5.5
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-31.14%
Return On Equity TTM
-55.8%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
18.0M
EBITDA
-31.7M
Diluted Eps TTM
-6.13
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-4.47
EPS Estimate Next Year
-3.6
EPS Estimate Current Quarter
-0.09
EPS Estimate Next Quarter
-0.1

Analyst Recommendation

Sell
    0
    0%Buy
    50%Hold
    50%Sell
Based on 8 Wall street analysts offering stock ratings for LANDOS BIOPHARMA INC(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
4
4
5
Sell
4
4
4

Analyst Forecast

What analysts predicted

Upside of 83.95%

Current $2.99
Target $5.50

Technicals Summary

Sell

Neutral

Buy

LANDOS BIOPHARMA INC is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
LANDOS BIOPHARMA INC
LANDOS BIOPHARMA INC
896.55%
1244.19%
297.96%
-75.92%
-75.92%
Moderna, Inc.
Moderna, Inc.
-5.37%
-28.24%
-13.14%
103.02%
578.71%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-10.12%
-3.55%
9.07%
20.95%
140.97%
Seagen, Inc.
Seagen, Inc.
-2.85%
59.4%
42.61%
21.68%
240.77%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-4.35%
4.3%
22.83%
15.12%
110.67%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
LANDOS BIOPHARMA INC
LANDOS BIOPHARMA INC
NA
NA
NA
-4.47
-0.56
-0.31
0.0
1.51
Moderna, Inc.
Moderna, Inc.
11.22
11.22
0.0
-1.83
0.27
0.12
0.0
49.12
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
19.72
19.72
9.01
41.59
0.19
0.1
0.0
219.38
Seagen, Inc.
Seagen, Inc.
NA
NA
18.53
-2.88
-0.23
-0.12
0.0
14.54
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
26.53
26.53
0.41
13.64
0.26
0.17
0.0
56.05
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
LANDOS BIOPHARMA INC
LANDOS BIOPHARMA INC
Sell
$90.1M
-75.92%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$48.1B
578.71%
11.22
31.77%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$79.5B
140.97%
19.72
33.81%
Seagen, Inc.
Seagen, Inc.
Hold
$36.3B
240.77%
NA
-31.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$85.0B
110.67%
26.53
35.4%

Institutional Holdings

  • Perceptive Advisors LLC

    47.71%
  • Macquarie Group Ltd

    0.47%
  • Geode Capital Management, LLC

    0.30%
  • Renaissance Technologies Corp

    0.25%
  • Warberg Asset Management LLC

    0.24%
  • HRT FINANCIAL LLC

    0.17%

Corporate Announcements

  • LANDOS BIOPHARMA INC Earnings

    LANDOS BIOPHARMA INC’s price-to-earnings ratio stands at None

    Read More

Company Information

Organization
LANDOS BIOPHARMA INC
Employees
22
CEO
Mr. Timothy M. Mayleben M.B.A.
Industry
Healthcare

FAQs